Gulf News

Covaxin neutralise­s double mutant strain

-

Indigenous­ly developed Covid-19 vaccine, Covaxin, neutralise­s multiple variants of SARS-CoV-2 and effectivel­y works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said yesterday.

Bharat Biotech’s Covaxin has received Emergency Use Authorisat­ions (EUAs) for Covid-19 treatment in India and in several countries across the globe with another 60 in the process.

“ICMR study shows Covaxin neutralise­s against multiple variants of SARS-CoV-2 and effectivel­y neutralise­s the double mutant strain as well,” the ICMR tweeted.

ICMR-National Institute of Virology has successful­ly isolated and cultured multiple variants of concern of SARS-CoV-2 virus: B.1.1.7 (the UK variant), B.1.1.28 (Brazil variant) and B.1.351 (South Africa variant).

Newspapers in English

Newspapers from United Arab Emirates